Related Experiment Video
Updated: Jun 12, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
Published on: December 29, 2021
Cannabis-based medicines in multiple sclerosis--a review of clinical studies
1Greater Manchester Neurosciences Centre, Stott Lane, Manchester M68HD, UK. David.Rog@srft.nhs.uk
Abstract:
For some years a mixture of anecdotal report and data from animal models have implied a potential role for cannabis-based medicines in ameliorating a variety of symptoms of multiple sclerosis. Only recently however have large randomised controlled trials (RCTs) examined these potential effects rigorously. At present the results of RCTs have lacked a coherent message to the prescribing clinician and reasons for such heterogeneity in cannabinoid trials are discussed.
Related Concept Videos
Multiple Sclerosis l: Introduction
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Mesenchymal Stem Cells
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

